Kiadis Pharma NV (Kiadis Pharma NV) Additional Paid-In Capital : $278.57 Mil(As of Dec. 2020)

View and export this data going back to 2016. Start your Free Trial

What is Kiadis Pharma NV Additional Paid-In Capital?

Kiadis Pharma NV's quarterly additional paid-in capital increased from Dec. 2019 ($244.49 Mil) to Jun. 2020 ($257.43 Mil) and increased from Jun. 2020 ($257.43 Mil) to Dec. 2020 ($278.57 Mil).

Kiadis Pharma NV's annual additional paid-in capital increased from Dec. 2018 ($205.41 Mil) to Dec. 2019 ($244.49 Mil) and increased from Dec. 2019 ($244.49 Mil) to Dec. 2020 ($278.57 Mil).

Kiadis Pharma NV Additional Paid-In Capital Historical Data

The historical data trend for Kiadis Pharma NV's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kiadis Pharma NV Additional Paid-In Capital Chart

Kiadis Pharma NV Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Additional Paid-In Capital

Get a 7-Day Free Trial

108.86

147.23

205.41

244.49

278.57

Kiadis Pharma NV Semi-Annual Data
	Dec12	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20
Additional Paid-In Capital	Get a 7-Day Free Trial											205.41	248.70	244.49	257.43	278.57

Kiadis Pharma NV Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Kiadis Pharma NV Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Kiadis Pharma NV's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Kiadis Pharma NV (Kiadis Pharma NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kiadis Pharma NV (GREY:KIADF) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

Paasheuvelweg 25A, Amsterdam, NLD, 1105 BP

Website

https://www.kiadis.com

Kiadis Pharma NV is a Netherlands based clinical-stage biopharmaceutical company. It is focused on research, development, and commercialization of cell-based immunotherapy products for the treatment of blood cancers and inherited blood disorders. The company's product pipeline includes K-NK002, K-NK003, K-NK00X, and others.

Kiadis Pharma NV (Kiadis Pharma NV) Headlines

No Headlines